KERI JOHNSON: Open Payments
NPI 1902256019 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 22 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $290 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $141 |
| Novo Nordisk Inc | 3 | $91 |
| Lilly USA, LLC | 2 | $77 |
| Collegium Pharmaceutical, Inc. | 1 | $26 |
| Echosens North America, Inc. | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
Products named: QULIPTA, Ozempic, ZEPBOUND, MOUNJARO, UBRELVY, Belbuca, Fibroscan, Rybelsus.
Industry payments across ID — which companies pay providers there.
